Natural Killer (NK) cells have long been the soldiers of the immune system that prevents the growth and spread of cancers, and subduing this army of cells is one of the key ways that tumors take hold.
Researchers have discovered a protein found in humans that prevents NK cells from doing their job fighting cancer. Importantly the study, published in the prestigious journal Science Signaling, reveals that blocking this protein - with a naturally occurring hormone currently commercially available - turbocharges the immune system to fight off the cancer cells.
The discovery, in preclinical models, means this hormone, called Follistatin, may be a new and highly potent immune-therapeutic drug for the eradication of cancers such as melanoma.
In the paper, the research team studied what are known as 'Natural Killer' cells in the immune system. These NK cells are crucial in protecting against the triggering of cancer and the spread or metastasizing of cancer cells.
One of the key reasons why cancer cells take hold and grow occurs when these NK cells are in some way suppressed. To date the signals that inhibit NK cells have remained largely a mystery.
The scientists found that a protein - called Activin-A - which is found naturally in both healthy human cells and cancer cells, directly disables the NK cell's capacity to halt cancer growth.
Authors showed that NK cells express the type I activin receptor ALK4, which, upon binding to its ligand activin-A, phosphorylated SMAD2/3 to suppress IL-15–mediated NK cell metabolism. Activin-A impaired human and mouse NK cell proliferation and reduced the production of granzyme B to impair tumor killing. Activin-A also induced SMAD2/3 phosphorylation and stimulated NK cells to increase their cell surface expression of several markers of ILC1 cells.
Importantly, they were able to block Activin-A in preclinical models, using human and mouse NK cell models, with the hormone Follistatin.
According to the senior author, "these findings may open the door to novel immune-therapy drugs which provide a deeper and more durable way to overcome the immune suppression seen in cancer, improving patient outcomes."
https://stke.sciencemag.org/content/12/596/eaat7527
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Ftherapeutic-blockade-of&filter=22
Unblocking the inhibition of body's natural killer cells to stop cancer
- 1,657 views
- Added
Edited
Latest News
Wiring of the human neocortex
By newseditor
Posted 24 Apr
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Other Top Stories
Turning off autophagy genes in myeloid cells provide protection aga…
Read more
How cells scramble to fix pores formed by microbial attacks
Read more
Modified sugar as a new antiviral treatment
Read more
How malaria parasites import sugar
Read more
Targeting autophagy to treat MERS coronavirus
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Harnessing gastrointestinal…
By newseditor
Posted 24 Apr
Sex-specific modulation of…
By newseditor
Posted 24 Apr
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar